img

Global Vaginal Antifungal Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Vaginal Antifungal Market Insights, Forecast to 2034

Market Analysis and InsightsGlobal Vaginal Antifungal Market
Global Vaginal Antifungal market is expected to reach to US$ million in 2023, with a positive growth of %, compared with US$ million in 2022. Backed with the increasing demand from downstream industries, Vaginal Antifungal industry is evaluated to reach US$ million in 2033. The CAGR will be % during 2023 to 2033.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers
This report presents an overview of global Vaginal Antifungal market from 2018 to 2033, aiming to help readers to get a comprehensive understanding of global Vaginal Antifungal market with multiple angles. Items like regional revenue from 2018 to 2033 and companies’ revenue and gross margin from 2018 to 2023 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2033 are also highlighted.
Companies, Type, Application and Regions Listed in the Report



By Company


ANI Pharmaceuticals
Lupin
Unique Pharmaceuticals
Pfizer
SCYNEXIS
Bausch Health Companies
Hikma Pharmaceuticals
Pacgen Life Science Corporation
Astellas Pharma
Mycovia Pharmaceuticals
PEPTONIC Medical
Segment by Type
Fluconazole
Clotrimazole
Ketoconazole
Others

Segment by Application


Hospital
Clinic
Pharmacy
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2033
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2033 globally
Chapter 5Product revenue analysis by application from 2018 to 2033 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2033 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2033
Chapter 7Product revenue analysis by type and application from 2018 to 2033 in Europe. Product revenue analysis of each country in Europe from 2018 to 2033
Chapter 8Product revenue analysis by type and application from 2018 to 2033 in China. Product revenue analysis of China from 2018 to 2033
Chapter 9Product revenue analysis by type and application from 2018 to 2033 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2033
Chapter 10Product revenue analysis by type and application from 2018 to 2033 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2033.
Chapter 11Companies’ outline, covering company’s basic information, major business, Vaginal Antifungal introduction, etc. Vaginal Antifungal Revenue and Gross Margin of each company from 2018 to 2023
Chapter 12MRAResearch’s Conclusions of Vaginal Antifungal
Chapter 13Methodology and Data Sources adopted by MRAResearch

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Vaginal Antifungal Market Size Growth Rate by Type, 2018 VS 2022 VS 2033
1.2.2 Fluconazole
1.2.3 Clotrimazole
1.2.4 Ketoconazole
1.2.5 Others
1.3 Market by Application
1.3.1 Global Vaginal Antifungal Market Size Growth Rate by Application, 2018 VS 2022 VS 2033
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Pharmacy
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Vaginal Antifungal Market Perspective (2018-2033)
2.2 Global Vaginal Antifungal Growth Trends by Region
2.2.1 Vaginal Antifungal Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Vaginal Antifungal Historic Market Size by Region (2018-2023)
2.2.3 Vaginal Antifungal Forecasted Market Size by Region (2024-2033)
2.3 Vaginal Antifungal Market Dynamics
2.3.1 Vaginal Antifungal Industry Trends
2.3.2 Vaginal Antifungal Market Drivers
2.3.3 Vaginal Antifungal Market Challenges
2.3.4 Vaginal Antifungal Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Vaginal Antifungal by Players
3.1.1 Global Vaginal Antifungal Revenue by Players (2018-2023)
3.1.2 Global Vaginal Antifungal Revenue Market Share by Players (2018-2023)
3.2 Global Vaginal Antifungal Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Vaginal Antifungal, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Vaginal Antifungal Market Concentration Ratio
3.4.1 Global Vaginal Antifungal Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Vaginal Antifungal Revenue in 2022
3.5 Global Key Players of Vaginal Antifungal Head office and Area Served
3.6 Global Key Players of Vaginal Antifungal, Product and Application
3.7 Global Key Players of Vaginal Antifungal, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Vaginal Antifungal Breakdown Data by Type
4.1 Global Vaginal Antifungal Historic Market Size by Type (2018-2023)
4.2 Global Vaginal Antifungal Forecasted Market Size by Type (2024-2033)
5 Vaginal Antifungal Breakdown Data by Application
5.1 Global Vaginal Antifungal Historic Market Size by Application (2018-2023)
5.2 Global Vaginal Antifungal Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Vaginal Antifungal Market Size (2018-2033)
6.2 North America Vaginal Antifungal Market Size by Type
6.2.1 North America Vaginal Antifungal Market Size by Type (2018-2023)
6.2.2 North America Vaginal Antifungal Market Size by Type (2024-2033)
6.2.3 North America Vaginal Antifungal Market Share by Type (2018-2033)
6.3 North America Vaginal Antifungal Market Size by Application
6.3.1 North America Vaginal Antifungal Market Size by Application (2018-2023)
6.3.2 North America Vaginal Antifungal Market Size by Application (2024-2033)
6.3.3 North America Vaginal Antifungal Market Share by Application (2018-2033)
6.4 North America Vaginal Antifungal Market Size by Country
6.4.1 North America Vaginal Antifungal Market Size by Country: 2018 VS 2022 VS 2033
6.4.2 North America Vaginal Antifungal Market Size by Country (2018-2023)
6.4.3 North America Vaginal Antifungal Market Size by Country (2024-2033)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Vaginal Antifungal Market Size (2018-2033)
7.2 Europe Vaginal Antifungal Market Size by Type
7.2.1 Europe Vaginal Antifungal Market Size by Type (2018-2023)
7.2.2 Europe Vaginal Antifungal Market Size by Type (2024-2033)
7.2.3 Europe Vaginal Antifungal Market Share by Type (2018-2033)
7.3 Europe Vaginal Antifungal Market Size by Application
7.3.1 Europe Vaginal Antifungal Market Size by Application (2018-2023)
7.3.2 Europe Vaginal Antifungal Market Size by Application (2024-2033)
7.3.3 Europe Vaginal Antifungal Market Share by Application (2018-2033)
7.4 Europe Vaginal Antifungal Market Size by Country
7.4.1 Europe Vaginal Antifungal Market Size by Country: 2018 VS 2022 VS 2033
7.4.2 Europe Vaginal Antifungal Market Size by Country (2018-2023)
7.4.3 Europe Vaginal Antifungal Market Size by Country (2024-2033)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Vaginal Antifungal Market Size (2018-2033)
8.2 China Vaginal Antifungal Market Size by Type
8.2.1 China Vaginal Antifungal Market Size by Type (2018-2023)
8.2.2 China Vaginal Antifungal Market Size by Type (2024-2033)
8.2.3 China Vaginal Antifungal Market Share by Type (2018-2033)
8.3 China Vaginal Antifungal Market Size by Application
8.3.1 China Vaginal Antifungal Market Size by Application (2018-2023)
8.3.2 China Vaginal Antifungal Market Size by Application (2024-2033)
8.3.3 China Vaginal Antifungal Market Share by Application (2018-2033)
9 Asia (excluding China)
9.1 Asia Vaginal Antifungal Market Size (2018-2033)
9.2 Asia Vaginal Antifungal Market Size by Type
9.2.1 Asia Vaginal Antifungal Market Size by Type (2018-2023)
9.2.2 Asia Vaginal Antifungal Market Size by Type (2024-2033)
9.2.3 Asia Vaginal Antifungal Market Share by Type (2018-2033)
9.3 Asia Vaginal Antifungal Market Size by Application
9.3.1 Asia Vaginal Antifungal Market Size by Application (2018-2023)
9.3.2 Asia Vaginal Antifungal Market Size by Application (2024-2033)
9.3.3 Asia Vaginal Antifungal Market Share by Application (2018-2033)
9.4 Asia Vaginal Antifungal Market Size by Region
9.4.1 Asia Vaginal Antifungal Market Size by Region: 2018 VS 2022 VS 2033
9.4.2 Asia Vaginal Antifungal Market Size by Region (2018-2023)
9.4.3 Asia Vaginal Antifungal Market Size by Region (2024-2033)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Vaginal Antifungal Market Size (2018-2033)
10.2 Middle East, Africa, and Latin America Vaginal Antifungal Market Size by Type
10.2.1 Middle East, Africa, and Latin America Vaginal Antifungal Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Vaginal Antifungal Market Size by Type (2024-2033)
10.2.3 Middle East, Africa, and Latin America Vaginal Antifungal Market Share by Type (2018-2033)
10.3 Middle East, Africa, and Latin America Vaginal Antifungal Market Size by Application
10.3.1 Middle East, Africa, and Latin America Vaginal Antifungal Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Vaginal Antifungal Market Size by Application (2024-2033)
10.3.3 Middle East, Africa, and Latin America Vaginal Antifungal Market Share by Application (2018-2033)
10.4 Middle East, Africa, and Latin America Vaginal Antifungal Market Size by Country
10.4.1 Middle East, Africa, and Latin America Vaginal Antifungal Market Size by Country: 2018 VS 2022 VS 2033
10.4.2 Middle East, Africa, and Latin America Vaginal Antifungal Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Vaginal Antifungal Market Size by Country (2024-2033)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 ANI Pharmaceuticals
11.1.1 ANI Pharmaceuticals Company Details
11.1.2 ANI Pharmaceuticals Business Overview
11.1.3 ANI Pharmaceuticals Vaginal Antifungal Introduction
11.1.4 ANI Pharmaceuticals Revenue in Vaginal Antifungal Business (2018-2023)
11.1.5 ANI Pharmaceuticals Recent Developments
11.2 Lupin
11.2.1 Lupin Company Details
11.2.2 Lupin Business Overview
11.2.3 Lupin Vaginal Antifungal Introduction
11.2.4 Lupin Revenue in Vaginal Antifungal Business (2018-2023)
11.2.5 Lupin Recent Developments
11.3 Unique Pharmaceuticals
11.3.1 Unique Pharmaceuticals Company Details
11.3.2 Unique Pharmaceuticals Business Overview
11.3.3 Unique Pharmaceuticals Vaginal Antifungal Introduction
11.3.4 Unique Pharmaceuticals Revenue in Vaginal Antifungal Business (2018-2023)
11.3.5 Unique Pharmaceuticals Recent Developments
11.4 Pfizer
11.4.1 Pfizer Company Details
11.4.2 Pfizer Business Overview
11.4.3 Pfizer Vaginal Antifungal Introduction
11.4.4 Pfizer Revenue in Vaginal Antifungal Business (2018-2023)
11.4.5 Pfizer Recent Developments
11.5 SCYNEXIS
11.5.1 SCYNEXIS Company Details
11.5.2 SCYNEXIS Business Overview
11.5.3 SCYNEXIS Vaginal Antifungal Introduction
11.5.4 SCYNEXIS Revenue in Vaginal Antifungal Business (2018-2023)
11.5.5 SCYNEXIS Recent Developments
11.6 Bausch Health Companies
11.6.1 Bausch Health Companies Company Details
11.6.2 Bausch Health Companies Business Overview
11.6.3 Bausch Health Companies Vaginal Antifungal Introduction
11.6.4 Bausch Health Companies Revenue in Vaginal Antifungal Business (2018-2023)
11.6.5 Bausch Health Companies Recent Developments
11.7 Hikma Pharmaceuticals
11.7.1 Hikma Pharmaceuticals Company Details
11.7.2 Hikma Pharmaceuticals Business Overview
11.7.3 Hikma Pharmaceuticals Vaginal Antifungal Introduction
11.7.4 Hikma Pharmaceuticals Revenue in Vaginal Antifungal Business (2018-2023)
11.7.5 Hikma Pharmaceuticals Recent Developments
11.8 Pacgen Life Science Corporation
11.8.1 Pacgen Life Science Corporation Company Details
11.8.2 Pacgen Life Science Corporation Business Overview
11.8.3 Pacgen Life Science Corporation Vaginal Antifungal Introduction
11.8.4 Pacgen Life Science Corporation Revenue in Vaginal Antifungal Business (2018-2023)
11.8.5 Pacgen Life Science Corporation Recent Developments
11.9 Astellas Pharma
11.9.1 Astellas Pharma Company Details
11.9.2 Astellas Pharma Business Overview
11.9.3 Astellas Pharma Vaginal Antifungal Introduction
11.9.4 Astellas Pharma Revenue in Vaginal Antifungal Business (2018-2023)
11.9.5 Astellas Pharma Recent Developments
11.10 Mycovia Pharmaceuticals
11.10.1 Mycovia Pharmaceuticals Company Details
11.10.2 Mycovia Pharmaceuticals Business Overview
11.10.3 Mycovia Pharmaceuticals Vaginal Antifungal Introduction
11.10.4 Mycovia Pharmaceuticals Revenue in Vaginal Antifungal Business (2018-2023)
11.10.5 Mycovia Pharmaceuticals Recent Developments
11.11 PEPTONIC Medical
11.11.1 PEPTONIC Medical Company Details
11.11.2 PEPTONIC Medical Business Overview
11.11.3 PEPTONIC Medical Vaginal Antifungal Introduction
11.11.4 PEPTONIC Medical Revenue in Vaginal Antifungal Business (2018-2023)
11.11.5 PEPTONIC Medical Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Vaginal Antifungal Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2033
Table 2. Key Players of Fluconazole
Table 3. Key Players of Clotrimazole
Table 4. Key Players of Ketoconazole
Table 5. Key Players of Others
Table 6. Global Vaginal Antifungal Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2033
Table 7. Global Vaginal Antifungal Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 8. Global Vaginal Antifungal Market Size by Region (2018-2023) & (US$ Million)
Table 9. Global Vaginal Antifungal Market Share by Region (2018-2023)
Table 10. Global Vaginal Antifungal Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 11. Global Vaginal Antifungal Market Share by Region (2024-2033)
Table 12. Vaginal Antifungal Market Trends
Table 13. Vaginal Antifungal Market Drivers
Table 14. Vaginal Antifungal Market Challenges
Table 15. Vaginal Antifungal Market Restraints
Table 16. Global Vaginal Antifungal Revenue by Players (2018-2023) & (US$ Million)
Table 17. Global Vaginal Antifungal Revenue Share by Players (2018-2023)
Table 18. Global Top Vaginal Antifungal by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Vaginal Antifungal as of 2022)
Table 19. Global Vaginal Antifungal Industry Ranking 2021 VS 2022 VS 2023
Table 20. Global 5 Largest Players Market Share by Vaginal Antifungal Revenue (CR5 and HHI) & (2018-2023)
Table 21. Global Key Players of Vaginal Antifungal, Headquarters and Area Served
Table 22. Global Key Players of Vaginal Antifungal, Product and Application
Table 23. Global Key Players of Vaginal Antifungal, Product and Application
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Vaginal Antifungal Market Size by Type (2018-2023) & (US$ Million)
Table 26. Global Vaginal Antifungal Revenue Market Share by Type (2018-2023)
Table 27. Global Vaginal Antifungal Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 28. Global Vaginal Antifungal Revenue Market Share by Type (2024-2033)
Table 29. Global Vaginal Antifungal Market Size by Application (2018-2023) & (US$ Million)
Table 30. Global Vaginal Antifungal Revenue Share by Application (2018-2023)
Table 31. Global Vaginal Antifungal Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 32. Global Vaginal Antifungal Revenue Share by Application (2024-2033)
Table 33. North America Vaginal Antifungal Market Size by Type (2018-2023) & (US$ Million)
Table 34. North America Vaginal Antifungal Market Size by Type (2024-2033) & (US$ Million)
Table 35. North America Vaginal Antifungal Market Size by Application (2018-2023) & (US$ Million)
Table 36. North America Vaginal Antifungal Market Size by Application (2024-2033) & (US$ Million)
Table 37. North America Vaginal Antifungal Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 38. North America Vaginal Antifungal Market Size by Country (2018-2023) & (US$ Million)
Table 39. North America Vaginal Antifungal Market Size by Country (2024-2033) & (US$ Million)
Table 40. Europe Vaginal Antifungal Market Size by Type (2018-2023) & (US$ Million)
Table 41. Europe Vaginal Antifungal Market Size by Type (2024-2033) & (US$ Million)
Table 42. Europe Vaginal Antifungal Market Size by Application (2018-2023) & (US$ Million)
Table 43. Europe Vaginal Antifungal Market Size by Application (2024-2033) & (US$ Million)
Table 44. Europe Vaginal Antifungal Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 45. Europe Vaginal Antifungal Market Size by Country (2018-2023) & (US$ Million)
Table 46. Europe Vaginal Antifungal Market Size by Country (2024-2033) & (US$ Million)
Table 47. China Vaginal Antifungal Market Size by Type (2018-2023) & (US$ Million)
Table 48. China Vaginal Antifungal Market Size by Type (2024-2033) & (US$ Million)
Table 49. China Vaginal Antifungal Market Size by Application (2018-2023) & (US$ Million)
Table 50. China Vaginal Antifungal Market Size by Application (2024-2033) & (US$ Million)
Table 51. Asia Vaginal Antifungal Market Size by Type (2018-2023) & (US$ Million)
Table 52. Asia Vaginal Antifungal Market Size by Type (2024-2033) & (US$ Million)
Table 53. Asia Vaginal Antifungal Market Size by Application (2018-2023) & (US$ Million)
Table 54. Asia Vaginal Antifungal Market Size by Application (2024-2033) & (US$ Million)
Table 55. Asia Vaginal Antifungal Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 56. Asia Vaginal Antifungal Market Size by Region (2018-2023) & (US$ Million)
Table 57. Asia Vaginal Antifungal Market Size by Region (2024-2033) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Vaginal Antifungal Market Size by Type (2018-2023) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Vaginal Antifungal Market Size by Type (2024-2033) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Vaginal Antifungal Market Size by Application (2018-2023) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Vaginal Antifungal Market Size by Application (2024-2033) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Vaginal Antifungal Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 63. Middle East, Africa, and Latin America Vaginal Antifungal Market Size by Country (2018-2023) & (US$ Million)
Table 64. Middle East, Africa, and Latin America Vaginal Antifungal Market Size by Country (2024-2033) & (US$ Million)
Table 65. ANI Pharmaceuticals Company Details
Table 66. ANI Pharmaceuticals Business Overview
Table 67. ANI Pharmaceuticals Vaginal Antifungal Product
Table 68. ANI Pharmaceuticals Revenue in Vaginal Antifungal Business (2018-2023) & (US$ Million)
Table 69. ANI Pharmaceuticals Recent Developments
Table 70. Lupin Company Details
Table 71. Lupin Business Overview
Table 72. Lupin Vaginal Antifungal Product
Table 73. Lupin Revenue in Vaginal Antifungal Business (2018-2023) & (US$ Million)
Table 74. Lupin Recent Developments
Table 75. Unique Pharmaceuticals Company Details
Table 76. Unique Pharmaceuticals Business Overview
Table 77. Unique Pharmaceuticals Vaginal Antifungal Product
Table 78. Unique Pharmaceuticals Revenue in Vaginal Antifungal Business (2018-2023) & (US$ Million)
Table 79. Unique Pharmaceuticals Recent Developments
Table 80. Pfizer Company Details
Table 81. Pfizer Business Overview
Table 82. Pfizer Vaginal Antifungal Product
Table 83. Pfizer Revenue in Vaginal Antifungal Business (2018-2023) & (US$ Million)
Table 84. Pfizer Recent Developments
Table 85. SCYNEXIS Company Details
Table 86. SCYNEXIS Business Overview
Table 87. SCYNEXIS Vaginal Antifungal Product
Table 88. SCYNEXIS Revenue in Vaginal Antifungal Business (2018-2023) & (US$ Million)
Table 89. SCYNEXIS Recent Developments
Table 90. Bausch Health Companies Company Details
Table 91. Bausch Health Companies Business Overview
Table 92. Bausch Health Companies Vaginal Antifungal Product
Table 93. Bausch Health Companies Revenue in Vaginal Antifungal Business (2018-2023) & (US$ Million)
Table 94. Bausch Health Companies Recent Developments
Table 95. Hikma Pharmaceuticals Company Details
Table 96. Hikma Pharmaceuticals Business Overview
Table 97. Hikma Pharmaceuticals Vaginal Antifungal Product
Table 98. Hikma Pharmaceuticals Revenue in Vaginal Antifungal Business (2018-2023) & (US$ Million)
Table 99. Hikma Pharmaceuticals Recent Developments
Table 100. Pacgen Life Science Corporation Company Details
Table 101. Pacgen Life Science Corporation Business Overview
Table 102. Pacgen Life Science Corporation Vaginal Antifungal Product
Table 103. Pacgen Life Science Corporation Revenue in Vaginal Antifungal Business (2018-2023) & (US$ Million)
Table 104. Pacgen Life Science Corporation Recent Developments
Table 105. Astellas Pharma Company Details
Table 106. Astellas Pharma Business Overview
Table 107. Astellas Pharma Vaginal Antifungal Product
Table 108. Astellas Pharma Revenue in Vaginal Antifungal Business (2018-2023) & (US$ Million)
Table 109. Astellas Pharma Recent Developments
Table 110. Mycovia Pharmaceuticals Company Details
Table 111. Mycovia Pharmaceuticals Business Overview
Table 112. Mycovia Pharmaceuticals Vaginal Antifungal Product
Table 113. Mycovia Pharmaceuticals Revenue in Vaginal Antifungal Business (2018-2023) & (US$ Million)
Table 114. Mycovia Pharmaceuticals Recent Developments
Table 115. PEPTONIC Medical Company Details
Table 116. PEPTONIC Medical Business Overview
Table 117. PEPTONIC Medical Vaginal Antifungal Product
Table 118. PEPTONIC Medical Revenue in Vaginal Antifungal Business (2018-2023) & (US$ Million)
Table 119. PEPTONIC Medical Recent Developments
Table 120. Research Programs/Design for This Report
Table 121. Key Data Information from Secondary Sources
Table 122. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Vaginal Antifungal Market Size Growth Rate by Type, 2018 VS 2022 VS 2033 (US$ Million)
Figure 2. Global Vaginal Antifungal Market Share by Type: 2022 VS 2033
Figure 3. Fluconazole Features
Figure 4. Clotrimazole Features
Figure 5. Ketoconazole Features
Figure 6. Others Features
Figure 7. Global Vaginal Antifungal Market Size Growth Rate by Application, 2018 VS 2022 VS 2033 (US$ Million)
Figure 8. Global Vaginal Antifungal Market Share by Application: 2022 VS 2033
Figure 9. Hospital Case Studies
Figure 10. Clinic Case Studies
Figure 11. Pharmacy Case Studies
Figure 12. Vaginal Antifungal Report Years Considered
Figure 13. Global Vaginal Antifungal Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 14. Global Vaginal Antifungal Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 15. Global Vaginal Antifungal Market Share by Region: 2022 VS 2033
Figure 16. Global Vaginal Antifungal Market Share by Players in 2022
Figure 17. Global Top Vaginal Antifungal Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Vaginal Antifungal as of 2022)
Figure 18. The Top 10 and 5 Players Market Share by Vaginal Antifungal Revenue in 2022
Figure 19. North America Vaginal Antifungal Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 20. North America Vaginal Antifungal Market Share by Type (2018-2033)
Figure 21. North America Vaginal Antifungal Market Share by Application (2018-2033)
Figure 22. North America Vaginal Antifungal Market Share by Country (2018-2033)
Figure 23. United States Vaginal Antifungal Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. Canada Vaginal Antifungal Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. Europe Vaginal Antifungal Market Size YoY (2018-2033) & (US$ Million)
Figure 26. Europe Vaginal Antifungal Market Share by Type (2018-2033)
Figure 27. Europe Vaginal Antifungal Market Share by Application (2018-2033)
Figure 28. Europe Vaginal Antifungal Market Share by Country (2018-2033)
Figure 29. Germany Vaginal Antifungal Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. France Vaginal Antifungal Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. U.K. Vaginal Antifungal Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Italy Vaginal Antifungal Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Russia Vaginal Antifungal Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Nordic Countries Vaginal Antifungal Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. China Vaginal Antifungal Market Size YoY (2018-2033) & (US$ Million)
Figure 36. China Vaginal Antifungal Market Share by Type (2018-2033)
Figure 37. China Vaginal Antifungal Market Share by Application (2018-2033)
Figure 38. Asia Vaginal Antifungal Market Size YoY (2018-2033) & (US$ Million)
Figure 39. Asia Vaginal Antifungal Market Share by Type (2018-2033)
Figure 40. Asia Vaginal Antifungal Market Share by Application (2018-2033)
Figure 41. Asia Vaginal Antifungal Market Share by Region (2018-2033)
Figure 42. Japan Vaginal Antifungal Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. South Korea Vaginal Antifungal Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. China Taiwan Vaginal Antifungal Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Southeast Asia Vaginal Antifungal Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. India Vaginal Antifungal Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. Australia Vaginal Antifungal Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 48. Middle East, Africa, and Latin America Vaginal Antifungal Market Size YoY (2018-2033) & (US$ Million)
Figure 49. Middle East, Africa, and Latin America Vaginal Antifungal Market Share by Type (2018-2033)
Figure 50. Middle East, Africa, and Latin America Vaginal Antifungal Market Share by Application (2018-2033)
Figure 51. Middle East, Africa, and Latin America Vaginal Antifungal Market Share by Country (2018-2033)
Figure 52. Brazil Vaginal Antifungal Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 53. Mexico Vaginal Antifungal Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 54. Turkey Vaginal Antifungal Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 55. Saudi Arabia Vaginal Antifungal Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 56. Israel Vaginal Antifungal Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 57. GCC Countries Vaginal Antifungal Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 58. ANI Pharmaceuticals Revenue Growth Rate in Vaginal Antifungal Business (2018-2023)
Figure 59. Lupin Revenue Growth Rate in Vaginal Antifungal Business (2018-2023)
Figure 60. Unique Pharmaceuticals Revenue Growth Rate in Vaginal Antifungal Business (2018-2023)
Figure 61. Pfizer Revenue Growth Rate in Vaginal Antifungal Business (2018-2023)
Figure 62. SCYNEXIS Revenue Growth Rate in Vaginal Antifungal Business (2018-2023)
Figure 63. Bausch Health Companies Revenue Growth Rate in Vaginal Antifungal Business (2018-2023)
Figure 64. Hikma Pharmaceuticals Revenue Growth Rate in Vaginal Antifungal Business (2018-2023)
Figure 65. Pacgen Life Science Corporation Revenue Growth Rate in Vaginal Antifungal Business (2018-2023)
Figure 66. Astellas Pharma Revenue Growth Rate in Vaginal Antifungal Business (2018-2023)
Figure 67. Mycovia Pharmaceuticals Revenue Growth Rate in Vaginal Antifungal Business (2018-2023)
Figure 68. PEPTONIC Medical Revenue Growth Rate in Vaginal Antifungal Business (2018-2023)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries